Showing results (91-100 of 105) with videos related to
Sort By:
Pageof 11
Circulation|November 19, 2019
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFFelipe A Martinez, Matteo Serenelli, Jose C Nicolau, et al.Journal of the American College of Cardiology|April 18, 2015
Cardiovascular drug development: is it dead or just hibernating?Christopher B Fordyce, Matthew T Roe, Tariq Ahmad, et al.European Journal of Heart Failure|June 16, 2020
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HFPooja Dewan, Scott D Solomon, Pardeep S Jhund, et al.Circulation|November 19, 2019
Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction: Results From the DAPA-HF TrialMikhail N Kosiborod, Pardeep S Jhund, Kieran F Docherty, et al.The Journal of Clinical Investigation|April 29, 2010
Folate regulation of axonal regeneration in the rodent central nervous system through DNA methylationBermans J Iskandar, Elias Rizk, Brenton Meier, et al.European Heart Journal|March 30, 2020
Effects of dapagliflozin in DAPA-HF according to background heart failure therapyKieran F Docherty, Pardeep S Jhund, Silvio E Inzucchi, et al.The Lancet. Diabetes & Endocrinology|December 2, 2021
Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trialsPeter Rossing, Silvio E Inzucchi, Priya Vart, et al.Journal of Clinical Epidemiology|March 4, 2019
The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panelKenneth E Freedland, Abby C King, Walter T Ambrosius, et al.Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.Pageof 11